Ubiquitin-specific protease 13 modulates cisplatin resistance and ferroptosis of ovarian cancer by stabilizing LGR4 protein

IF 4.2 3区 农林科学 Q3 FOOD SCIENCE & TECHNOLOGY
Yongfeng Guo, Na Lu, Yun Cao, Jie Wang, Mingxiao Chen
{"title":"Ubiquitin-specific protease 13 modulates cisplatin resistance and ferroptosis of ovarian cancer by stabilizing LGR4 protein","authors":"Yongfeng Guo,&nbsp;Na Lu,&nbsp;Yun Cao,&nbsp;Jie Wang,&nbsp;Mingxiao Chen","doi":"10.1186/s13765-025-01056-z","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Ubiquitination, a crucial post-translational modification, plays a vital role in cancer progression. The present research focused on the function of ubiquitin-specific protease 13 (USP13) and its potential mechanism related to leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) in cisplatin (DDP) resistance and ferroptosis of ovarian cancer (OC).</p><h3>Methods</h3><p>Real-time quantitative PCR and Western blotting were used for mRNA and protein detection. The half-maximal inhibitory concentration (IC50) of DDP was determined using CCK-8 assay. Cell proliferation, apoptosis, and migration were assessed through colony formation/EdU assays, flow cytometry, and transwell/wound healing assays, respectively. Ferroptosis was analyzed by detecting reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), Fe<sup>2+</sup> level and protein marker expression. Co-immunoprecipitation (Co-IP) assay was applied for protein interaction and ubiquitination analysis. Xenograft studies were constructed for in vivo research.</p><h3>Results</h3><p>LGR4 expression was increased in DDP-resistant OC tissues and cell lines. After LGR4 was downregulated, chemoresistance and malignant characteristics such as proliferation and migration were suppressed while ferroptosis was promoted in DDP-resistant OC cells. USP13 served as a deubiquitinating enzyme to enhance LGR4 protein stability. USP13 inhibition attenuated DDP resistance and promoted ferroptosis by targeting LGR4. LGR4 knockdown could enhance chemosensitivity of tumor tissues to DDP in mice.</p><h3>Conclusion</h3><p>These findings elucidated that USP13 stabilized LGR4 protein to regulate DDP resistance and ferroptosis in OC. Targeting the USP13/LGR4 axis represents a potential therapeutic strategy to overcome DDP resistance in OC.</p><h3>Highlights</h3><ol>\n <li>\n <span>1.</span>\n \n <p>LGR4 inhibition reduces chemoresistance and promotes ferroptosis in cisplatin-resistant ovarian cancer cells.</p>\n \n </li>\n <li>\n <span>2.</span>\n \n <p>USP13 stabilizes LGR4 protein by deubiquitination.</p>\n \n </li>\n <li>\n <span>3.</span>\n \n <p>LGR4 can reverse the effects of USP13 knockdown on cisplatin resistance and ferroptosis</p>\n \n </li>\n </ol></div>","PeriodicalId":467,"journal":{"name":"Applied Biological Chemistry","volume":"68 1","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://applbiolchem.springeropen.com/counter/pdf/10.1186/s13765-025-01056-z","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Biological Chemistry","FirstCategoryId":"97","ListUrlMain":"https://link.springer.com/article/10.1186/s13765-025-01056-z","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Ubiquitination, a crucial post-translational modification, plays a vital role in cancer progression. The present research focused on the function of ubiquitin-specific protease 13 (USP13) and its potential mechanism related to leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) in cisplatin (DDP) resistance and ferroptosis of ovarian cancer (OC).

Methods

Real-time quantitative PCR and Western blotting were used for mRNA and protein detection. The half-maximal inhibitory concentration (IC50) of DDP was determined using CCK-8 assay. Cell proliferation, apoptosis, and migration were assessed through colony formation/EdU assays, flow cytometry, and transwell/wound healing assays, respectively. Ferroptosis was analyzed by detecting reactive oxygen species (ROS), malondialdehyde (MDA), glutathione (GSH), Fe2+ level and protein marker expression. Co-immunoprecipitation (Co-IP) assay was applied for protein interaction and ubiquitination analysis. Xenograft studies were constructed for in vivo research.

Results

LGR4 expression was increased in DDP-resistant OC tissues and cell lines. After LGR4 was downregulated, chemoresistance and malignant characteristics such as proliferation and migration were suppressed while ferroptosis was promoted in DDP-resistant OC cells. USP13 served as a deubiquitinating enzyme to enhance LGR4 protein stability. USP13 inhibition attenuated DDP resistance and promoted ferroptosis by targeting LGR4. LGR4 knockdown could enhance chemosensitivity of tumor tissues to DDP in mice.

Conclusion

These findings elucidated that USP13 stabilized LGR4 protein to regulate DDP resistance and ferroptosis in OC. Targeting the USP13/LGR4 axis represents a potential therapeutic strategy to overcome DDP resistance in OC.

Highlights

  1. 1.

    LGR4 inhibition reduces chemoresistance and promotes ferroptosis in cisplatin-resistant ovarian cancer cells.

  2. 2.

    USP13 stabilizes LGR4 protein by deubiquitination.

  3. 3.

    LGR4 can reverse the effects of USP13 knockdown on cisplatin resistance and ferroptosis

泛素特异性蛋白酶13通过稳定LGR4蛋白调节卵巢癌顺铂耐药和铁下垂
dubiquitination是一种重要的翻译后修饰,在癌症进展中起着至关重要的作用。本研究主要探讨泛素特异性蛋白酶13 (USP13)在卵巢癌顺铂耐药和铁凋亡中的作用及其与富亮氨酸重复-含g蛋白偶联受体4 (LGR4)相关的潜在机制。方法采用real -time定量PCR和Western blotting检测mRNA和蛋白。CCK-8法测定DDP的半最大抑制浓度(IC50)。细胞增殖、凋亡和迁移分别通过菌落形成/EdU测定、流式细胞术和跨井/伤口愈合测定进行评估。通过检测活性氧(ROS)、丙二醛(MDA)、谷胱甘肽(GSH)、铁离子(Fe2+)水平及蛋白标志物表达来分析铁下垂。共免疫沉淀法(Co-IP)用于蛋白相互作用和泛素化分析。异种移植物研究是为体内研究而构建的。结果slgr4在耐药OC组织和细胞系中表达升高。下调LGR4后,ddp耐药OC细胞的化疗耐药和增殖、迁移等恶性特征被抑制,铁下垂被促进。USP13作为去泛素化酶增强LGR4蛋白的稳定性。USP13抑制作用通过靶向LGR4减弱DDP耐药性,促进铁下垂。LGR4敲低可增强小鼠肿瘤组织对DDP的化学敏感性。结论USP13可稳定LGR4蛋白,调节OC对DDP的抗性和铁下垂。靶向USP13/LGR4轴是一种潜在的治疗策略,可以克服OC的DDP耐药。突出了 1。LGR4抑制降低顺铂耐药卵巢癌细胞的化疗耐药并促进铁下垂。2. USP13通过去泛素化作用稳定LGR4蛋白。3. LGR4可以逆转USP13基因敲低对顺铂耐药和铁下垂的影响
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Applied Biological Chemistry
Applied Biological Chemistry Chemistry-Organic Chemistry
CiteScore
5.40
自引率
6.20%
发文量
70
审稿时长
20 weeks
期刊介绍: Applied Biological Chemistry aims to promote the interchange and dissemination of scientific data among researchers in the field of agricultural and biological chemistry. The journal covers biochemistry and molecular biology, medical and biomaterial science, food science, and environmental science as applied to multidisciplinary agriculture.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书